496 related articles for article (PubMed ID: 31756952)
1. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
Itatani Y; Kawada K; Sakai Y
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
[TBL] [Abstract][Full Text] [Related]
2. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Ferns GA; Aghaee-Bakhtiari SH
Curr Pharm Des; 2018; 24(39):4611-4618. PubMed ID: 30636580
[TBL] [Abstract][Full Text] [Related]
3. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
4. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
5. Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
Dews M; Tan GS; Hultine S; Raman P; Choi J; Duperret EK; Lawler J; Bass A; Thomas-Tikhonenko A
J Natl Cancer Inst; 2014 Apr; 106(4):dju043. PubMed ID: 24627270
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Microenvironment in Advanced Colorectal Cancer.
Tauriello DVF; Batlle E
Trends Cancer; 2016 Sep; 2(9):495-504. PubMed ID: 28741478
[TBL] [Abstract][Full Text] [Related]
7. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers.
Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX
Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
[TBL] [Abstract][Full Text] [Related]
10. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
[TBL] [Abstract][Full Text] [Related]
11. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
12. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
[TBL] [Abstract][Full Text] [Related]
14. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer.
Maslankova J; Vecurkovska I; Rabajdova M; Katuchova J; Kicka M; Gayova M; Katuch V
World J Gastroenterol; 2022 Sep; 28(33):4744-4761. PubMed ID: 36156927
[TBL] [Abstract][Full Text] [Related]
15. Role of the transforming growth factor-β signaling pathway in the pathogenesis of colorectal cancer.
Soleimani A; Pashirzad M; Avan A; Ferns GA; Khazaei M; Hassanian SM
J Cell Biochem; 2019 Jun; 120(6):8899-8907. PubMed ID: 30556274
[TBL] [Abstract][Full Text] [Related]
16. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
[TBL] [Abstract][Full Text] [Related]
17. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
Calon A; Espinet E; Palomo-Ponce S; Tauriello DV; Iglesias M; Céspedes MV; Sevillano M; Nadal C; Jung P; Zhang XH; Byrom D; Riera A; Rossell D; Mangues R; Massagué J; Sancho E; Batlle E
Cancer Cell; 2012 Nov; 22(5):571-84. PubMed ID: 23153532
[TBL] [Abstract][Full Text] [Related]
18. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes.
Baker K; Chong G; Foulkes WD; Jass JR
Histopathology; 2006 Oct; 49(4):371-80. PubMed ID: 16978200
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling alterations and susceptibility to colorectal cancer.
Xu Y; Pasche B
Hum Mol Genet; 2007 Apr; 16 Spec No 1(SPEC):R14-20. PubMed ID: 17613544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
